Exact Sciences Sees FY24 Revenue $2.81B-$2.85B Vs $2.83B Est.
Portfolio Pulse from Benzinga Newsdesk
Exact Sciences projects its 2024 revenue to be between $2.81 billion and $2.85 billion, closely aligning with the estimated $2.83 billion. This forecast includes screening revenue of $2.155-$2.175 billion and precision oncology revenue of $655-$675 million.
February 21, 2024 | 9:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exact Sciences expects 2024 revenues to range from $2.81B to $2.85B, with significant contributions from screening and precision oncology.
The revenue forecast by Exact Sciences is in line with analysts' expectations, indicating a positive outlook for the company's growth, particularly in its screening and precision oncology segments. This alignment with estimates suggests a stable financial trajectory, likely leading to a positive investor sentiment in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100